Genetic liability to Alzheimer's disease is associated with a 149% increased risk of .
Genetic analysis showed a significant association between Alzheimer's disease and cerebral microbleeds, with an odds ratio of 1.149.
A modest increase in white matter hyperintensity volume was observed with a genetic predisposition to Alzheimer's disease.
The causal effects on cerebral microbleeds and remained significant even after accounting for other risk factors.
Colocalization analysis indicated a shared genetic variant between Alzheimer's disease and both cerebral microbleeds and white matter hyperintensities.
Findings suggest that genetic susceptibility to Alzheimer's disease may contribute to the development of certain cerebrovascular conditions.
Simplified
Observational studies have produced inconsistent findings regarding the relationship between Alzheimer's disease (AD) and cerebral small vessel disease (CSVD) risk. Residual confounding and potential reverse causality are inevitable in such conventional observational studies. We tried to examine the causal relationship between AD and CSVD-related phenotypes using genetic methods. Genetic instruments for each AD and CSVD-related phenotypes (, white matter hyperintensity, and lacunar stroke) were derived from large-scale genome-wide association studies. In this study, two-sample (MR) tested potential causal associations between AD and CSVD-related phenotypes, followed by a colocalization analysis to corroborate MR findings and explain possible mechanisms. Using univariable MR, we observed that genetic liability to AD was associated with an increased risk of cerebral microbleeds (CMBs) [odds ratio (OR) = 1.149; 95% confidence interval (CI) = 1.070-1.235, P < 0.001], and a modest increase in (WMHs) volume (β = 0.031 mm, 95% CI = 0.009-0.054 mm, P = 0.005). In multivariable MR, the causal effect of genetic liability for AD on CMBs and WMHs remained after adjusting for risk factors, with the estimate across the IVW method. Colocalization results provided evidence for a shared causal variant between AD with CMBs (PPH4 = 0.996) and WMHs (PPH4 = 0.657), suggesting that the MR estimates were not confounded by linkage disequilibrium. Our MR analyses provided robust evidence for the causal effects of genetic liability for AD on an increased risk of CMBs and WMHs. More work is warranted to confirm the mechanisms of association between AD and CSVD. 3 3
Key numbers
1.149
Increase in CMB risk
for genetic liability to affecting .
0.031 mm
Increase in WMH volume
β value for genetic liability to affecting .
Full Text
We can’t show the full text here under this license.
Competing interests: The authors declare no competing interests. Compliance with ethics guidelines: This study used publicly available deidentified data from participant studies that were approved by an ethical standards committee with respect to human experimentation.
Alzheimers & Treatments